Jihong Lian
Edmonton, AB T6G2S2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
CES1 Increases Hepatic Triacylglycerol Synthesis Through Activation of PPARγ, LXR and SREBP1c.
Journal: Cells
Published: August 11, 2025
Preferential lipolysis of DGAT1 over DGAT2 generated triacylglycerol in Huh7 hepatocytes.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: December 08, 2022
Attenuation of obesity-induced hyperlipidemia reduces tumor growth.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: August 02, 2021
Carboxylesterase 1d (Ces1d) does not contribute to cholesteryl ester hydrolysis in the liver.
Journal: Journal of lipid research
Published: May 29, 2021
Ces1d deficiency protects against high-sucrose diet-induced hepatic triacylglycerol accumulation.
Journal: Journal of lipid research
Published: January 16, 2019
Fasting and refeeding induces changes in the mouse hepatic lipid droplet proteome.
Journal: Journal of proteomics
Published: December 22, 2017
Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: November 26, 2017
Loss of Calreticulin Uncovers a Critical Role for Calcium in Regulating Cellular Lipid Homeostasis.
Journal: Scientific reports
Published: March 27, 2017
Carboxylesterases in lipid metabolism: from mouse to human.
Journal: Protein & cell
Published: March 02, 2017
Liver-specific expression of carboxylesterase 1g/esterase-x reduces hepatic steatosis, counteracts dyslipidemia and improves insulin signaling.
Journal: Biochimica et biophysica acta
Published: October 24, 2015
Ces3/TGH Deficiency Attenuates Steatohepatitis.
Journal: Scientific reports
Published: October 23, 2015
Tumor-Induced Hyperlipidemia Contributes to Tumor Growth.
Journal: Cell reports
Published: July 17, 2015
Last Updated: 09/26/2026